Jiangxi Xinganjiang Pharmaceutical Co (BJSE:873167) ROCE % : 12.95% (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Jiangxi Xinganjiang Pharmaceutical Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Jiangxi Xinganjiang Pharmaceutical Co's annualized ROCE % for the quarter that ended in Mar. 2024 was 12.95%.

Jiangxi Xinganjiang Pharmaceutical Co ROCE % Historical Data

The historical data trend for Jiangxi Xinganjiang Pharmaceutical Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangxi Xinganjiang Pharmaceutical Co ROCE % Chart

Jiangxi Xinganjiang Pharmaceutical Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

16.82

24.31

26.13

20.51

13.89

Jiangxi Xinganjiang Pharmaceutical Co Quarterly Data
	Jun18	Dec18	Jun19	Sep19	Dec19	Jun20	Sep20	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															21.87	13.51	8.13	6.19	12.95

Jiangxi Xinganjiang Pharmaceutical Co ROCE % Calculation

Jiangxi Xinganjiang Pharmaceutical Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	52.926	/	( ( (353.875 - 69.628)	+	(521.933 - 44.081) )	/ 2 )
	=	52.926	/	( (284.247	+	477.852)	/ 2 )
	=	52.926	/	381.0495
	=	13.89 %

Jiangxi Xinganjiang Pharmaceutical Co's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	62.812	/	( ( (521.933 - 44.081)	+	(532.452 - 40.167) )	/ 2 )
	=	62.812	/	( ( 477.852	+	492.285 )	/ 2 )
	=	62.812	/	485.0685
	=	12.95 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Jiangxi Xinganjiang Pharmaceutical Co (BJSE:873167) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Jiangxi Xinganjiang Pharmaceutical Co ROCE % Related Terms

Thank you for viewing the detailed overview of Jiangxi Xinganjiang Pharmaceutical Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Jiangxi Xinganjiang Pharmaceutical Co (BJSE:873167) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiangxi Xinganjiang Pharmaceutical Co Ltd (BJSE:873167) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

No. 36 Yunzhang Road, Jizhou District, Jiangxi Province, Ji'an City, CHN, 343000

Website

http://www.xgjyy.com

Jiangxi Xinganjiang Pharmaceutical Co Ltd research and development, production, and sales of chemical raw materials, chemical preparations, and Chinese patent medicines. The company's raw material medicine products are mainly calcium gluconate, zinc gluconate, ferrous gluconate and other gluconate series raw material medicines. Its main chemical preparations are vitamin C chewable tablets and compound Yinqiao aminomin capsules, Phenaminokamin Tablets.

Jiangxi Xinganjiang Pharmaceutical Co (BJSE:873167) Headlines

No Headlines